SCHEMBL21189301

SCHEMBL21189301

Cc1cc(NC(=O)c2ccc(F)c3c2OCC[C@@H]3NC(=O)OC[C@@H]2CC(=O)N2)ccc1F

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 8/20 0.34
HTR2B P41595 1/20 0.33
DRD4 P21917 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CASP6 P55212 1/20 0.32
PIK3CD O00329 1/20 0.32
CYP3A4 P08684 1/20 0.32
AKT1 P31749 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189295 0.92 IRAK4 (0.35) GRM4HTR2BDRD4TMEM97SIGMAR1
SCHEMBL21189298 0.92 IRAK4 (0.35) GRM4HTR2BDRD4TMEM97SIGMAR1
SCHEMBL21189362 0.91 IRAK4 (0.35) GRM4HTR2BDRD4TMEM97SIGMAR1
SCHEMBL21189191 0.91 ALDH1A1 (0.37) GRM4NPC1RAB9A
SCHEMBL21189433 0.85 APOB (0.40) HTR2BDRD4TMEM97SIGMAR1NPC1
SCHEMBL21189248 0.85 APOB (0.40) HTR2BDRD4TMEM97SIGMAR1NPC1
SCHEMBL21189312 0.84 DRD4 (0.33) GRM4HTR2BDRD4TMEM97SIGMAR1
SCHEMBL21189314 0.84 DRD4 (0.33) GRM4HTR2BDRD4TMEM97SIGMAR1
SCHEMBL21189307 0.83 HDAC3 (0.38) GRM4HTR2BDRD4TMEM97SIGMAR1
SCHEMBL21189302 0.82 NPC1 (0.36) GRM4HTR2BDRD4TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS GRM4 3439/4885HTR2B 2367/4885DRD4 4324/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS GRM4 3439/4885HTR2B 2367/4885DRD4 4324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.